Will the partnership with Genentech/Roche on xl-518 (GDC-0973) lead us to the promised land?Zelboraf is already approved and Genentech wouldn't be making the investment in a P3 w/o at least suspecting that a combo will increase the chances that Zelboraf becomes another blockbuster (in combination).
It's even totally possible that RHHBY has been behind the conspiracy (yes, I said it!) to keep EXEL's pps lower so that they don't have to pay a huge premium when they buy out EXEL. The P2 results must have been known for a while and were impressive enough for Genentech to spend a lot of money on this P3 test.
No mj525252 I don't dream about it, but I wouldn't buy a lottery ticket if I didn't think about it. You're no newcomer and you've been around long enough to have seen many of my posts and if you don't like my optimism you are free to put me on ignore.